Biotechnology (445) | Registration Rights Agreements (445)

Browse by Company

2seventy bio, Inc. (1 contract)
AbbVie Inc. (1)
ABEONA THERAPEUTICS INC. (2)
ACHIEVE LIFE SCIENCES, INC. (2)
Acorda Therapeutics (1)
ADiTx Therapeutics, Inc. (2)
Advaxis, Inc. (3)
Aeglea BioTherapeutics, Inc. (1)
AgeX Therapeutics, Inc. (4)
AILERON THERAPEUTICS INC (2)
Aimmune Therapeutics, Inc. (2)
Alector, Inc. (1)
Allarity Therapeutics, Inc. (2)
Allena Pharmaceuticals, Inc. (1)
Alpha Healthcare Acquisition Corp. (2)
ALPINE IMMUNE SCIENCES, INC. (3)
Amgen Inc. (1)
AmpliPhi Biosciences Corp (5)
Amplitude Healthcare Acquisition Corp (3)
ANAVEX LIFE SCIENCES CORP. (2)
Annovis Bio, Inc. (1)
Applied Therapeutics Inc. (1)
Aprea Therapeutics, Inc. (2)
Aptevo Therapeutics Inc. (3)
Aptose Biosciences Inc. (1)
Aravive, Inc. (2)
Arcturus Therapeutics Holdings Inc. (1)
Arcutis Biotherapeutics, Inc. (1)
Arsanis, Inc. (6)
ARYA Sciences Acquisition Corp II (3)
Athenex, Inc. (3)
ATHERSYS, INC (3)
Atreca, Inc. (1)
aTYR PHARMA INC (1)
Avid Bioservices, Inc. (1)
Avidity Biosciences, Inc. (1)
AZIYO BIOLOGICS, INC. (1)
AzurRx BioPharma, Inc. (4)
BCTG Acquisition Corp. (1)
BeiGene, Ltd. (1)
BICYCLE THERAPEUTICS Ltd (1)
Big Cypress Acquisition Corp. (3)
BioCardia, Inc. (2)
BIOVIE INC. (2)
BIOXYTRAN, INC (1)
Bison Capital Acquisition Corp. (1)
Blue Water Vaccines Inc. (2)
bluebird bio, Inc. (2)
BridgeBio Pharma, Inc. (3)
CALADRIUS BIOSCIENCES, INC. (3)
CANCER GENETICS, INC (2)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (3)
CATABASIS PHARMACEUTICALS INC (2)
Celcuity Inc. (1)
Cellectar Biosciences, Inc. (3)
Celsion CORP (2)
Centessa Pharmaceuticals Ltd (2)
Chanticleer Holdings, Inc. (1)
Chardan Healthcare Acquisition 2 Corp. (3)
Chardan Healthcare Acquisition Corp. (2)
Chelsea Worldwide Inc. (1)
Cibus Global, Ltd. (1)
CLEVELAND BIOLABS INC (1)
CM Life Sciences III Inc. (5)
Comera Life Sciences Holdings, Inc. (3)
Conatus Pharmaceuticals Inc. (4)
Consonance-HFW Acquisition Corp. (3)
Constellation Alpha Capital Corp. (3)
CONSTELLATION PHARMACEUTICALS INC (1)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (2)
CTD HOLDINGS INC (1)
Cue Biopharma, Inc. (1)
Cullinan Oncology, LLC (2)
CURIS INC (1)
CYTORI THERAPEUTICS, INC. (2)
CYTRX CORP (1)
DBV Technologies S.A. (1)
DelMar Pharmaceuticals, Inc. (1)
Dermavant Sciences Ltd (1)
DiaMedica Therapeutics Inc. (1)
Digital Development Partners, Inc. (1)
Dynamics Special Purpose Corp. (3)
Edge Therapeutics, Inc. (1)
Emerald Bioscience, Inc. (1)
Emergent BioSolutions Inc. (1)
ENDONOVO THERAPEUTICS, INC. (2)
Enochian Biosciences Inc (1)
Entasis Therapeutics Holdings Inc. (6)
Environmental Impact Acquisition Corp (2)
Equillium, Inc. (1)
EXICURE, INC. (2)
Flex Pharma, Inc. (1)
Frequency Therapeutics, Inc. (1)
FS Development Corp. (3)
FS Development Corp. II (3)
Fusion Pharmaceuticals Inc. (2)
Gamida Cell Ltd. (1)
Gemphire Therapeutics Inc. (2)
GENEREX BIOTECHNOLOGY CORP (4)
GENOCEA BIOSCIENCES, INC. (1)
GeoVax Labs, Inc. (2)
Greater Cannabis Company, Inc. (1)
Greenwich LifeSciences, Inc. (1)
GT Biopharma, Inc. (6)
GX Acquisition Corp. (5)
Harpoon Therapeutics, Inc. (1)
Health Sciences Acquisitions Corp (3)
HISTOGENICS CORP (1)
HOOKIPA Pharma Inc. (1)
HUMANIGEN, INC (1)
iBio, Inc. (1)
IDERA PHARMACEUTICALS, INC. (5)
IGM Biosciences, Inc. (1)
Inhibikase Therapeutics, Inc. (1)
InMed Pharmaceuticals Inc. (5)
Inmune Bio, Inc. (1)
Innovation Pharmaceuticals Inc. (1)
INOVIO PHARMACEUTICALS, INC. (1)
Inozyme Pharma, Inc. (1)
Intec Parent Inc. (2)
Intec Pharma Ltd. (1)
Intrinsic Medicine, Inc. (1)
Invitae Corp (14)
Isoray, Inc. (1)
Jounce Therapeutics, Inc. (1)
Karyopharm Therapeutics Inc. (1)
KBL MERGER CORP. IV (4)
Kodiak Sciences Inc. (1)
Kymera Therapeutics, Inc. (1)
LEAP THERAPEUTICS, INC. (2)
Leisure Acquisition Corp. (2)
LifeSci Acquisition Corp. (3)
Locust Walk Acquisition Corp. (5)
LONGEVERON LLC (1)
MARIZYME INC (1)
Marker Therapeutics, Inc. (2)
MATEON THERAPEUTICS INC (4)
Millendo Therapeutics, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (3)
Moleculin Biotech, Inc. (2)
Monopar Therapeutics (4)
Morphic Holding, Inc. (1)
NAVIDEA BIOPHARMACEUTICALS, INC. (3)
NEUROTROPE BIOSCIENCE, INC. (3)
NTN BUZZTIME INC (5)
Nuvectis Pharma, Inc. (1)
Ohr Pharmaceutical Inc (1)
Olivia Ventures, Inc. (2)
OncBioMune Pharmaceuticals, Inc (1)
ONCOSEC MEDICAL Inc (5)
Organicell Regenerative Medicine, Inc. (1)
Orgenesis Inc. (3)
Pasithea Therapeutics Corp. (1)
Petra Acquisition Inc. (6)
Phio Pharmaceuticals Corp. (2)
PIERIS PHARMACEUTICALS, INC. (1)
POLARITYTE, INC. (2)
PRECISION BIOSCIENCES INC (1)
Prelude Therapeutics Inc (1)
PREMIER BIOMEDICAL INC (1)
ProMIS Neurosciences Inc. (2)
Propanc Biopharma, Inc. (4)
PROTEON THERAPEUTICS INC (1)
PROTEOSTASIS THERAPEUTICS, INC. (5)
Q BioMed Inc. (1)
Rallybio Corp (2)
RAPT Therapeutics, Inc. (1)
RECURSION PHARMACEUTICALS, INC. (1)
REGENERX BIOPHARMACEUTICALS INC (1)
Relay Therapeutics, Inc. (1)
Repare Therapeutics Inc. (1)
REXAHN PHARMACEUTICALS, INC. (1)
Rezolute, Inc. (4)
RITTER PHARMACEUTICALS INC (3)
ROCKET PHARMACEUTICALS, INC. (1)
Savara Inc (1)
SELECTA BIOSCIENCES INC (3)
SELLAS Life Sciences Group, Inc. (1)
Sesen Bio, Inc. (1)
Shuttle Pharmaceuticals Holdings, Inc. (1)
Social Capital Suvretta Holdings Corp. III (3)
Solid Biosciences Inc. (3)
SOLIGENIX, INC. (1)
Sorrento Therapeutics, Inc. (4)
Spinning Eagle Acquisition Corp. (5)
SpringWorks Therapeutics, Inc. (1)
Summit Therapeutics Inc. (1)
Sunshine Biopharma, Inc (2)
Syros Pharmaceuticals, Inc. (3)
T2 Biosystems, Inc. (2)
Taysha Gene Therapies, Inc. (1)
TENAX THERAPEUTICS, INC. (3)
Therapeutics Acquisition Corp. (4)
Tonix Pharmaceuticals Holding Corp. (6)
Tracon Pharmaceuticals, Inc. (1)
Translate Bio, Inc. (2)
Trovagene, Inc. (1)
TScan Therapeutics, Inc. (1)
Twist Bioscience Corp (2)
TYME TECHNOLOGIES, INC. (1)
Unity Biotechnology, Inc. (1)
Unum Therapeutics Inc. (2)
USA EQUITIES CORP. (2)
VACCINEX, INC. (7)
Vaccitech plc (2)
Vaxxinity, Inc. (2)
VERACYTE, INC. (1)
VICAL INC (2)
Vigil Neuroscience, Inc. (1)
vTv Therapeutics Inc. (1)
WINDTREE THERAPEUTICS INC (1)
Xenetic Biosciences, Inc. (1)
Xilio Therapeutics, Inc. (1)
ZAFGEN, INC. (3)
ZIOPHARM ONCOLOGY INC (2)
Zymeworks Inc. (1)

Recent Contracts

Registration Rights Agreement, dated March 22, 2023, by and among the Company and the Purchasers (Harpoon Therapeutics, Inc., Filed With SEC on March 27, 2023)
Form of Registration Rights Agreement (AzurRx BioPharma, Inc., Filed With SEC on March 15, 2023)
Registration Rights Agreement, dated as of March 7, 2023, between the Company and the investor party thereto (Invitae Corp, Filed With SEC on March 8, 2023)
Registration Rights Agreement, dated March 7, 2023 (Sesen Bio, Inc., Filed With SEC on March 8, 2023)
Registration Rights Agreement, dated March 3, 2023, by and between Clene Inc. and Lincoln Park Capital Fund, LLC (Chelsea Worldwide Inc., Filed With SEC on March 3, 2023)
Form of Registration Rights Agreement (Invitae Corp, Filed With SEC on March 1, 2023)
Form of Registration Rights Agreement (Allarity Therapeutics, Inc., Filed With SEC on February 28, 2023)
Form of Registration Rights Agreement (Chardan Healthcare Acquisition Corp., Filed With SEC on February 22, 2023)
Registration Rights Agreement, dated February 13, 2023, by and among Fusion Pharmaceuticals Inc. and the Investors named therein (Fusion Pharmaceuticals Inc., Filed With SEC on February 14, 2023)
Registration Rights Agreement, dated February 13, 2023, by and among Fusion Pharmaceuticals Inc. and the Investors named therein (Fusion Pharmaceuticals Inc., Filed With SEC on February 13, 2023)
Registration Rights Agreement, dated February 13, 2023, by and among Morphic Holding, Inc. and the investors listed on the signature pages thereto (Morphic Holding, Inc., Filed With SEC on February 13, 2023)
Registration Rights Agreement, dated February 3, 2023, by and between the Company and Lincoln Park Capital Fund, LLC (ANAVEX LIFE SCIENCES CORP., Filed With SEC on February 7, 2023)
Form of Registration Rights and Lock-Up Agreement dated as of January 31, 2023 (Isoray, Inc., Filed With SEC on February 6, 2023)
Registration Rights Agreement, dated as of January 25, 2023 (PIPE) (Inhibikase Therapeutics, Inc., Filed With SEC on January 26, 2023)
Registration Rights Agreement, dated January 17, 2023, by and among the Company and the Holders (LEAP THERAPEUTICS, INC., Filed With SEC on January 23, 2023)
Form of Registration Rights Agreement (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on January 12, 2023)
Registration Rights Agreement dated January 4, 2023, by and among Comera Life Sciences Holdings, Inc. and the Purchasers defined therein (Comera Life Sciences Holdings, Inc., Filed With SEC on January 4, 2023)
Form of Registration Rights Agreement (FS Development Corp., Filed With SEC on December 29, 2022)
Registration Rights Agreement, dated December 22, 2022, by and between Indaptus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Intec Parent Inc., Filed With SEC on December 23, 2022)
Registration Rights Agreement, dated December 22, 2022, by and between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt (RITTER PHARMACEUTICALS INC, Filed With SEC on December 22, 2022)
Registration Rights Agreement, dated as of December 13, 2022, between the Company and Mast Hill Fund, L.P (Digital Development Partners, Inc., Filed With SEC on December 21, 2022)
Registration Rights Agreement (Emerald Bioscience, Inc., Filed With SEC on December 19, 2022)
Form of Securities Purchase and Registration Rights Agreement, dated December 14, 2022, by and among the Company and the Investors (BioCardia, Inc., Filed With SEC on December 15, 2022)
Registration Rights Agreement, dated as of December 12, 2022, by and between the Company and Lincoln Park (Marker Therapeutics, Inc., Filed With SEC on December 13, 2022)
Registration Rights Agreement, dated December 12, 2022 by and among Gamida Cell Ltd., Gamida Cell Inc., and the entities listed on the signature pages thereto (Gamida Cell Ltd., Filed With SEC on December 12, 2022)
Registration Rights Agreement, dated as of December 2, 2022, by and among Eterna Therapeutics Inc. and the purchasers party thereto (NTN BUZZTIME INC, Filed With SEC on December 5, 2022)
Registration Rights Agreement, dated December 5, 2022, by and among the Company and the other parties thereto (Karyopharm Therapeutics Inc., Filed With SEC on December 5, 2022)
Form of Amendment No. 2 to the Registration Rights Agreement, dated December 5, 2022 (PROTEOSTASIS THERAPEUTICS, INC., Filed With SEC on December 5, 2022)
Form of Registration Rights Agreement (AzurRx BioPharma, Inc., Filed With SEC on November 22, 2022)
Registration Rights Agreement (InMed Pharmaceuticals Inc., Filed With SEC on November 22, 2022)
Form of Registration Rights Agreement (ACHIEVE LIFE SCIENCES, INC., Filed With SEC on November 18, 2022)
Form of Registration Rights Agreement (NEUROTROPE BIOSCIENCE, INC., Filed With SEC on November 18, 2022)
Registration Rights Agreement, dated November 14, 2022, by and among the Company and the other parties thereto (Cue Biopharma, Inc., Filed With SEC on November 15, 2022)
Registration Rights Agreement dated November 2, 2022 (Olivia Ventures, Inc., Filed With SEC on November 9, 2022)
Amended and Restated Registration Rights Agreement, dated August 15, 2022, by and between BioVie Inc. and Acuitas Group Holdings, LLC (BIOVIE INC., Filed With SEC on November 4, 2022)
Form of Registration Rights Agreement (ABEONA THERAPEUTICS INC., Filed With SEC on November 3, 2022)
Registration Rights Agreement by and between ProMIS Neurosciences Inc. and various investors (ProMIS Neurosciences Inc., Filed With SEC on November 1, 2022)
Registration Rights Agreement, by and between the Company and Astellas, dated October 21, 2022 (Taysha Gene Therapies, Inc., Filed With SEC on October 31, 2022)
Form of Affiliate Registration Rights Agreement, by and among Aravive, Inc. and the persons party thereto (Aravive, Inc., Filed With SEC on October 26, 2022)
Form of Registration Rights Agreement by and among Aravive, Inc. and the persons party thereto (Aravive, Inc., Filed With SEC on October 26, 2022)